05/08/2026
LETTER FROM THE PRESIDENT
Trust Is Built Where No One Is Looking
An implant is something almost no patient will ever see. The clinician handles it for a few seconds before placing it where it will remain for years. Patients cannot verify its quality with their own eyes—they simply trust it. And that trust is one of the most important responsibilities in our industry.
In previous letters, I wrote about precision, consistency, and the choices we make every day. Ultimately, they all serve the same purpose: to make that trust deserved. An implant is not defined only by titanium or design. It is defined by the confidence it gives clinicians and by the long-term reliability patients depend on.
Trust is one of the most frequently used words in our industry, yet it cannot be created through marketing. It is built in the details no one sees: the inspections performed on every component, the five-micron tolerances maintained throughout production, the traceability of every titanium bar, and the manufacturing discipline behind every implant.
This is also why we rely on independent validation. Universities, ISO certifications, laboratory testing, and fatigue validation are not marketing tools—they are proof that our work can be verified by others. Because true trust is never self-declared.
Trust must also be earned every single day. Every implant leaving our production facility carries the responsibility of confirming the reputation built over more than two decades of manufacturing experience. The IML brand was founded in 2013, but the expertise behind it dates back much further. Trust belongs to craftsmanship, not to a logo.
At IML, we do not ask clinicians simply to believe us. We ask them to verify what we do.
Because trust is not what we say.
It is what we prove.
Giovanni Canino
Founder & President · IML SA
